Nick Eliovits
Nichola’s investment expertise spans across asset classes, with a focus on venture capital, having led dozens of investments in technology and biotechnology companies. He is a Co-founder and Chief Business Officer at DermBiont, a company developing live biotherapeutics to treat skin diseases. Nichola has seeded and structured several early stage companies and led his previous startup through acquisition.
He graduated from Boston University's Questrom School of Business with concentrations in finance and accounting and started his career in commodity markets on Wall Street at CPM Group in New York.
